Drugs / H9N2 virosome vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00814229 Comparator | Aug 2007 → Jan 2008 | influenza | University Hospitals, Leicester | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H9N2 virosome vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00814229 ↗ |
| Modality | Vaccine | “adjuvanted and non-adjuvanted whole virus and virosomal H9N2 vaccines” NCT00814229 ↗ |
| Route | Intramuscular | “by intramuscular injection into the deltoid muscle” NCT00814229 ↗ |